Publikationer 2017/Kurt Boman

 

1. Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events. Bang CN, Greve AM, Rossebø AB, Ray S, Egstrup K, Boman K, Nienaber C, Okin PM, Devereux RB, Wachtell K. J Am Heart Assoc. 2017 Nov 27;6(12). pii: e006709. doi: 10.1161/JAHA.117.006709

 

2. Symptom Relief and Palliative Care during the Last Week of Life among Patients with Heart Failure: A National Register Study. Årestedt K, Alvariza A, Boman K, Öhlén J, Goliath I, Håkanson C, Fürst CJ, Brännström M. J Palliat Med. 2017 Oct 19. doi: 10.1089/jpm.2017.0125. [Epub ahead of print.

 

3. Anaemia, but not iron deficiency, is associated with clinical symptoms and quality of life in patients with severe heart failure and palliative home care: A substudy of the PREFER trial.Boman K, Olofsson M, Bergman AR, Brännström M.Eur J Intern Med. 2017 Dec;46:35-40. doi: 10.1016/j.ejim.2017.08.027. Epub 2017 Sep 9.

 

4. Patients' experiences of person-centred integrated heart failure care and palliative care at home: an interview study.Talabani N, Ängerud KH, Boman K, Brännström M. BMJ Support Palliat Care. 2017 Jul 7. pii: bmjspcare-2016-001226. doi: 10.1136/bmjspcare-2016-001226. [Epub ahead of print]

 

5. Areas for quality improvements in heart failure care: quality of care from the family members' perspective. Ängerud KH, Boman K, Brännström M. Scand J Caring Sci. 2017 May 24. doi: 10.1111/scs.12468. [Epub ahead of print]

 

6. Family members' experiences of integrated palliative advanced home and heart failure care: A qualitative study of the PREFER intervention. Alvariza A, Årestedt K, Boman K, Brännström M.Palliat Support Care. 2017 May 3:1-8. doi: 10.1017/S1478951517000256. [Epub ahead of print]

 

7. Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis.Lønnebakken MT, De Simone G, Saeed S, Boman K, Rossebø AB, Bahlmann E, Gohlke-Bärwolf C, Gerdts E. Heart. 2017 Sep;103(18):1443-1448. doi: 10.1136/heartjnl-2016-310917. Epub 2017 Apr 28.

 

8. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial. Rautio A, Boman K, Gerstein HC, Hernestål-Boman J, Lee SF, Olofsson M, Mellbin LG. Diab Vasc Dis Res. 2017 Jul;14(4):345-352. doi: 10.1177/1479164117703034. Epub 2017 Apr 12.

 

9. Longitudinal 10-year changes in dietary intake and associations with cardio-metabolic risk factors in the Northern Sweden Health and Disease Study. Winkvist A, Klingberg S, Nilsson LM, Wennberg M, Renström F, Hallmans G, Boman K, Johansson I. Nutr J. 2017 Mar 28;16(1):20. doi: 10.1186/s12937-017-0241-x.

 

10. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators. N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17. Boman K

 

11. The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study. Karlström P, Johansson P, Dahlström U, Boman K, Alehagen U. Int J Cardiol. 2017 Jun 1;236:315-320. doi: 10.1016/j.ijcard.2017.02.054. Epub 2017 Feb 17.

 

12. Comparison of Frequency of Ischemic Cardiovascular Events in Patients With Aortic Stenosis With Versus Without Asymmetric Septal Hypertrophy (from the SEAS Trial). Einarsen E, Cramariuc D, Lønnebakken MT, Boman K, Gohlke-Bärwolf C, Chambers JB, Gerdts E. Am J Cardiol. 2017 Apr 1;119(7):1082-1087. doi: 10.1016/j.amjcard.2016.11.064. Epub 2017 Jan 6.

 

13. A client-centred programme focusing energy conservation for people with heart failure. Norberg EB, Löfgren B, Boman K, Wennberg P, Brännström M. Scand J Occup Ther. 2017 Nov;24(6):455-467. doi: 10.1080/11038128.2016.1272631. Epub 2017 Jan 5.

 

14. Areas for quality improvements in heart failure care: quality of care from the patient's perspective. Ängerud KH, Boman K, Ekman I, Brännström M. Scand J Caring Sci. 2017 Dec;31(4):830-838. doi: 10.1111/scs.12404. Epub 2016 Nov 18.

 

15. Decreasing prevalence of abdominal aortic aneurysm and changes in cardiovascular risk factors. Persson SE, Boman K, Wanhainen A, Carlberg B, Arnerlöv C. J Vasc Surg. 2017 Mar;65(3):651-658. doi: 10.1016/j.jvs.2016.08.091. Epub 2016 Oct 25.

 

 16.Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study. Mancusi C, Gerdts E, de Simone G, Midtbø H, Lønnebakken MT, Boman K, Wachtell K, Dahlöf B, Devereux RB. Blood Press. 2017 Jun;26(3):150-155. doi: 10.1080/08037051.2016.1243009. Epub 2016 Nov 24.

 

 

 

Stöd vår forskning redan idag

Så hjälper du till

Stiftelsen vill inspirera och stödja yngre men även äldre läkare, sjuksköterskor, apotekare med flera till att forska inom områdena medicin och omvårdnad inom Skellefteå sjukvård (kommunerna Skellefteå och Norsjö).

Postgiro & Bankgiro

Stöd vår verksamhet genom att sätta in pengar på följande Post- och Bankgiro:

Stiftelsens postgiro 444 81 29-9
Stiftelsens bankgiro 710-9721
Stiftelsens swish 1233351574
Org nr 89 47 01-2384

Dela vår hemsida

Hjälp vår stiftelse och våra forskare genom att sprida vår sida vidare via sociala medier.
Information om cookies